Webinar Teaser: LBA Vs. LC-MS
Source: Aliri Bioanalysis
Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?
In a recent webinar, bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explored the advantages of LC-MS in speed, cost, and data specificity.
Discover key advancements in biomarker discovery, the challenges of analyzing transgenically expressed proteins, and why LC-MS may be the better choice for your next large molecule program.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Aliri Bioanalysis
This website uses cookies to ensure you get the best experience on our website. Learn more